Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

China flag China · Delayed Price · Currency is CNY
8.04
+0.46 (6.07%)
Mar 10, 2026, 2:05 PM CST
12.45%
Market Cap 3.85B
Revenue (ttm) 410.00M
Net Income (ttm) 39.53M
Shares Out 507.51M
EPS (ttm) 0.08
PE Ratio 97.91
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,406,336
Average Volume 16,221,762
Open 7.37
Previous Close 7.58
Day's Range 7.37 - 8.14
52-Week Range 5.66 - 8.43
Beta 0.52
RSI 69.76
Earnings Date Apr 28, 2026

About SHE:002198

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meiz... [Read more]

Sector Healthcare
Founded 2003
Employees 594
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002198
Full Company Profile

Financial Performance

In 2024, SHE:002198's revenue was 376.17 million, a decrease of -29.46% compared to the previous year's 533.23 million. Earnings were 20.61 million, a decrease of -39.94%.

Financial Statements

News

There is no news available yet.